Carla Nester
0000-0002-0629-7576
Publication & Citation Trends
Publications
0 total
WCN26-7416 IPTACOPAN TREATMENT IN PATIENTS WITH C3 GLOMERULOPATHY (C3G): 12-MONTH RESULTS FROM THE MANAGED ACCESS PROGRAM
Cited by 0
Semantic Scholar
WCN26-9116 EFFICACY OF PEGCETACOPLAN IN PATIENTS WITH LOWER BASELINE PROTEINURIA: A SUBGROUP ANALYSIS FROM THE VALIANT TRIAL
Cited by 0
Semantic Scholar
WCN26-5461 ORAL IPTACOPAN THERAPY IN C3 GLOMERULOPATHY SHOWS CONSISTENT STABILIZATION OF eGFR SLOPE ACROSS PATIENT SUBGROUPS
Cited by 0
Semantic Scholar
WCN26-9046 PEGCETACOPLAN FOR 52 WEEKS MAINTAINS PROTEINURIA REDUCTION AND EGFR STABILIZATION FOR PEDIATRIC PATIENTS: PHASE 3 VALIANT SUBGROUP ANALYSIS
Cited by 0
Semantic Scholar
WCN26-6813 PEGCETACOPLAN FOR 52-WEEKS MAINTAINED PROTEINURIA REDUCTION REGARDLESS OF IMMUNOSUPPRESSANT USE OR NEPHROTIC RANGE PROTEINURIA AT BASELINE: VALIANT SUBGROUP ANALYSIS
Cited by 0
Semantic Scholar
WCN26-3819 UPDATE TO THE LONG-TERM EFFICACY AND SAFETY OF IPTACOPAN IN C3 GLOMERULOPATHY: 39-MONTH PHASE 2 EXTENSION STUDY DATA
Cited by 0
Semantic Scholar
Research Topics
Renal Diseases and Glomerulopathies
(114)
Complement system in diseases
(101)
Coagulation, Bradykinin, Polyphosphates, and Angioedema
(24)
Blood groups and transfusion
(21)
Vasculitis and related conditions
(16)
Affiliations
Hershey (United States)
University of Iowa
Pennsylvania State University
RTI International
GTx (United States)